With a market capitalization of $13.5 billion, Masco Corporation (MAS) is an industrial company and a leading manufacturer of branded home improvement and building products. Headquartered in Livonia, Michigan, Masco operates globally with a substantial manufacturing and distribution footprint. Companies worth $10 billion or more are generally described as "large-cap stocks," and MAS fits the criterion. Masco is recognized for its strong brand portfolio and market share in plumbing and decorative products ...

Valued at a market cap of $12.9 billion, Wynn Resorts, Limited (WYNN) is a global luxury hospitality and gaming company that develops and operates high-end integrated resorts featuring casinos, hotels, fine dining, retail, and entertainment. The Las Vegas, Nevada-based company’s portfolio includes flagship properties in Las Vegas and Macau, with additional exposure through its Boston-area resort. Companies worth $10 billion or more are typically classified as “large-cap stocks,” and WYNN fits the label p ...

Pittsburgh, Pennsylvania-based EQT Corporation (EQT) explores and produces natural gas, with a primary focus on the Appalachian Basin in Ohio, Pennsylvania, and West Virginia. Valued at $34.7 billion by market cap, EQT sells natural gas and natural gas liquids to marketers, utilities, and industrial customers through its pipelines. Companies worth $10 billion or more are generally described as "large-cap stocks." EQT fits right into that category, with its market cap exceeding this threshold, reflecting ...

Core Insights - Cboe Global Markets, Inc. (CBOE) is a significant player in the financial exchange sector with a market capitalization of $26.1 billion, operating one of the largest derivatives and securities exchanges globally [1][2] Company Performance - CBOE's stock is currently trading 4.8% below its 52-week high of $262.98, achieved on November 12, and has seen a 5.7% increase over the past three months, outperforming the State Street Financial Select Sector SPDR ETF (XLF) [3] - Over the past 52 weeks, CBOE shares have surged 23.3%, significantly outpacing XLF's 9.3% increase, and on a year-to-date basis, CBOE is up 27.8% compared to XLF's 12.6% return [4] - Following a strong Q3 earnings report on October 31, CBOE's shares rose 3.7%, with total revenue reaching a record $1.1 billion, an 8.1% year-over-year increase, and adjusted EPS hitting a record high of $2.67, up 20.3% from the previous year [5] Competitive Position - CBOE has outperformed its competitor, Intercontinental Exchange, Inc. (ICE), which saw a 2% increase over the past 52 weeks and an 8.2% rise year-to-date [6] - Despite CBOE's strong performance, analysts maintain a cautious outlook, with a consensus rating of "Hold" and a mean price target of $256.86, indicating a 2.4% premium to current price levels [6]

With a market cap of $25.4 billion, Cincinnati Financial Corporation (CINF) is a provider of property and casualty insurance products. The company operates through five key segments, offering a wide range of commercial, personal, excess and surplus, life insurance, and investment services. Companies valued at more than $10 billion are generally considered "large-cap" stocks, and Cincinnati Financial fits this criterion perfectly. In addition to insurance solutions, it also provides commercial leasing, fin ...

Core Insights - Coterra Energy Inc. (CTRA) is an independent oil and gas company with a market cap of $20.5 billion, focusing on exploration, development, and production across the U.S. [1] - The company operates in key regions including the Permian Basin, Marcellus Shale, and Anadarko Basin, and also manages natural gas and saltwater gathering and disposal systems [1][2] Stock Performance - CTRA shares have decreased by 10.2% from their 52-week high of $29.95, but have increased by 10.4% over the past three months, outperforming the iShares U.S. Oil & Gas Exploration & Production ETF (IEO) which gained 4.6% [3] - Over the past 52 weeks, CTRA stock has risen by 8.5%, again outperforming IEO's marginal return, while year-to-date (YTD) performance shows a 5.4% increase, slightly lagging behind IEO's 5.8% rise [4] Q3 2025 Results - Following the Q3 2025 results released on November 3, CTRA shares climbed nearly 6% as total production reached 785 MBoepd, with oil production at 166.8 MBopd and natural gas at 2,894.6 MMcfpd, all exceeding mid-point guidance [5] - The company raised its full-year 2025 production guidance and reaffirmed an expected free cash flow of approximately $2 billion, alongside a commitment to shareholder returns through resumed share repurchases [5] Analyst Sentiment - Despite underperforming compared to rivals like Expand Energy Corporation (EXE), which saw a YTD increase of nearly 18%, analysts maintain a bullish outlook on CTRA with a consensus rating of "Strong Buy" [6] - The mean price target for CTRA is $32.46, indicating a potential upside of 20.8% from current levels [6]

Morningstar noted the strength in midcap funds. Those focused on the growth factor have been performing especially well this year. Traders worried about large-cap stocks hitting peak valuations may want to step into the midcap arena. Long- and short-term traders can also take advantage of future upside if the market environment shifts in favor of these companies. They offer midcap valuations, but not middling performance. Much of the stock market performance in 2025 has been fueled by artificial intelligenc ...

With a market cap of $19 billion, Vernon Hills, Illinois-based CDW Corporation (CDW) is a leading provider of information technology solutions across the United States, United Kingdom, and Canada, serving corporate, small business, and public sector clients. The company delivers a wide range of hardware, software, and integrated IT services, including hybrid infrastructure, digital experience, and security solutions. Companies worth more than $10 billion are generally described as “large-cap” stocks, and ...

Core Insights - Exelon Corporation (EXC) is a utility services holding company with a market cap of $44.4 billion, focusing on electricity and natural gas distribution and transmission [1] - The company serves a diverse clientele, including residential, commercial, industrial, governmental, public authority, and transportation sectors [2] Stock Performance - Exelon shares have declined 9.5% from their 52-week high of $48.51, while the stock has risen 1.3% over the past three months, underperforming the Nasdaq Composite's 8.3% return [3] - Year-to-date, Exelon stock is up 16.7%, lagging behind the Nasdaq's 21.7% surge, and has increased 16% over the past 52 weeks compared to the Nasdaq's 19.1% gain [4] Financial Results - On November 4, Exelon reported strong Q3 2025 results, with GAAP and adjusted operating earnings increasing to $0.86 per share from $0.70 and $0.71 per share in Q3 2024, respectively [5] - The company reaffirmed its full-year 2025 adjusted EPS guidance of $2.64 - $2.74 and a long-term operating EPS growth target of 5% - 7% through 2028 [5] Analyst Outlook - Despite underperforming relative to the Nasdaq, analysts maintain a moderately optimistic view on Exelon, with a consensus rating of "Moderate Buy" from 19 analysts and a mean price target of $50, representing a 13.9% premium to current levels [6]

Company Overview - Agilent Technologies, Inc. has a market cap of $42.3 billion and provides application-focused solutions for life sciences, diagnostics, and applied chemical markets globally [1] - The company operates through three segments: Life Sciences and Applied Markets; Diagnostics and Genomics; and Agilent CrossLab, offering a wide range of instruments, consumables, software, and laboratory services [1] Stock Performance - Agilent's shares have decreased by 6.9% from its 52-week high of $160.27, but have increased by 19.2% over the past three months, outperforming The Health Care Select Sector SPDR Fund's (XLV) 13.3% gain during the same period [3] - Over the past 52 weeks, Agilent's stock has risen by 7.2%, surpassing XLV's 5.6% return, but is up only 11.1% year-to-date, lagging behind XLV's 12.7% return [4] Financial Results - Following its Q4 2025 results, Agilent's shares rose by 2.3%, with revenue of $1.86 billion exceeding estimates and adjusted EPS of $1.59 meeting expectations [5] - Key segments showed strong performance, with Life Sciences and Diagnostics revenue at $755 million and a 7% increase in CrossLab revenue to $775 million [5] - The company projects fiscal 2026 revenue between $7.3 billion and $7.4 billion, with adjusted EPS expected to be between $5.86 and $6 [5] Competitive Landscape - Despite Agilent's positive outlook, rival Eli Lilly and Company has outperformed, with LLY stock surging 33.9% year-to-date and 27.1% over the past 52 weeks [6] - Analysts maintain a moderately optimistic view on Agilent, with a consensus rating of "Moderate Buy" from 17 analysts and a mean price target of $169.62, indicating a 13.6% premium to current levels [6]